Since ch5E6 recognizes a post-cleavage-generated unique epitope of MUC16, we established its clinical pertinence by checking its expression in PC and NSCLC patients’ tumors through immunohistochemical (IHC) staining. Here, MUC16 is linked to non-small cell lung carcinoma.